HealthcareNasdaqsmall
Institutional-grade research for retail investors
SEC EDGAR: CIK 849146LFVN stock profile & AI dashboard →

13F Pro Quality Score

40.6/100

Rank #2,098 of 2,962 stocks

View Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.

Revenue Growth

13.8/100

Profitability

38.0/100

Balance Sheet

78.4/100

Earnings Quality

84.7/100

Free Cash Flow

37.7/100

Institutional Flow

4.2/100

Revenue Scale

22.6/100

Dilution Risk

50.2/100
Email me the moment this company reports earnings
AI Research Report
Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.
Upgrade to Pro
Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.

LFVN Stock Analysis & AI Quality Score

Data updated 2026-09-11

AI stock analysis and institutional research for Lifevantage Corp (LFVN), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores LFVN at 40.6/100 on a 32-signal composite quality model, placing it at rank #2,098 of 2,962 stocks — the bottom half of the AI-ranked universe. LFVN scores in the top quartile across earnings quality (84.7), balance sheet strength (78.4). Areas of concern include institutional flow (4.2) and revenue growth (13.8), which score below median versus the broader universe. Based on the latest XBRL financial filings (Q2 2026), Lifevantage Corp reports quarterly revenue of $42.4M, net income of $1.3M, an operating margin of 3.9%. Top institutional holders of LFVN by reported 13-F value include CAPITAL MANAGEMENT, RENAISSANCE TECHNOLOGIES, VANGUARD CAPITAL MANAGEMENT, based on the most recent SEC filings. LFVN trades on the Nasdaq exchange and files with the SEC under CIK 849146. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate LFVN daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Lifevantage Corp directly from SEC EDGAR. Lifevantage Corp's 13F Pro composite quality score has ranged between 24 and 56 since 2021, currently 40.6 — a declining long-term trajectory across 68 quarterly and live scoring snapshots.

Fun facts about Lifevantage Corp

Quirks, history, and lore behind LFVN — the kind of stuff that makes a stock memorable.

  • 1
    The Basics
    U.S. healthcare company · small-cap · listed on Nasdaq · headquartered in Utah.
  • 2
    The Numbers
    Annual revenue in the range of roughly $200 million, with a direct-sales network doing most of the heavy lifting — no store shelves required.
  • 3
    The History
    Founded in the early 2000s, the company built its business around a single flagship antioxidant supplement before slowly expanding its product line.
  • 4
    The Secret
    Its products lean hard into Nrf2 activation — a cellular pathway that sounds like a sci-fi plot device but is a real area of nutrigenomics research.
  • 5
    The Lore
    Its best-known product, Protandim, got a burst of fame from a ABC News segment and has been cited in peer-reviewed studies, which is not something most supplement companies can say.
  • 6
    The Giveaway
    A Utah-based MLM-style wellness company whose flagship Protandim Nrf2 Synergizer promises to fight oxidative stress — and whose ticker literally spells out "life advantage."
▶ Think you know your stocks? Play the Daily Ticker

Revenue

Q2 2026

$42.4M

Net Income

Q2 2026

$1.3M

Free Cash Flow

Q2 2026

$3.7M

Operating Margin

Q2 2026

3.9%

ROIC

Q2 2026

19.9%

Period

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro

Revenue

-20.1% YoY
$182.6MFY 2026
FY23 $213.4MFY24 $200.2MFY25 $228.5MFY26 $182.6M

Net Income

-48.3% YoY
$5.1MFY 2026
FY23 $2.5MFY24 $2.9MFY25 $9.8MFY26 $5.1M

Operating Income

-50.0% YoY
$6.1MFY 2026
FY23 $4.3MFY24 $4.3MFY25 $12.2MFY26 $6.1M

EPS (Diluted)

-46.7% YoY
$0.40FY 2026
FY23 $0.20FY24 $0.23FY25 $0.75FY26 $0.40

Total Assets

-13.7% YoY
$62.1MFY 2026
FY23 $66.1MFY24 $60.3MFY25 $72.0MFY26 $62.1M

Op. Cash Flow

-13.8% YoY
$10.2MFY 2026
FY23 $6.8MFY24 $12.2MFY25 $11.9MFY26 $10.2M

Free Cash Flow

-36.5% YoY
$6.7MFY 2026
FY23 $3.8MFY24 $10.0MFY25 $10.5MFY26 $6.7M

Get alerted when LFVN's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for Lifevantage Corp including:

SEC EDGAR filings (10-K, 10-Q, 8-K)
XBRL financial facts (revenue, EPS, margins)
Insider transactions (Form 4)
Institutional 13F holdings
Quality rankings (32 signals)
AI analyst debates & daily meetings
Historical financial trends
Peer comparison & sector analysis

Companies Similar to LFVN

Ranked by quality-profile closeness and shared hedge-fund ownership — not just sector membership.

ANIK

Anika Therapeutics, Inc.

32
AI score
Similar quality profile · 3 shared holders
BTMD

biote Corp.

42
AI score
Similar quality profile
NATR

NATURES SUNSHINE PRODUCTS INC

51
AI score
Similar quality profile · 1 shared holders
PBYI

PUMA BIOTECHNOLOGY, INC.

48
AI score
Similar quality profile · 2 shared holders
MHH

Mastech Digital, Inc.

37
AI score
Shared smart-money ownership · 3 shared holders
EMBC

Embecta Corp.

50
AI score
Similar quality profile · 2 shared holders
ARAY

ACCURAY INC

26
AI score
Similar quality profile · 1 shared holders
TCMD

TACTILE SYSTEMS TECHNOLOGY INC

56
AI score
Similar quality profile · 1 shared holders

Similarity is computed from the 8 composite sub-scores and latest-quarter 13F conviction holdings (index-style filers excluded). Refreshed monthly.

Put LFVN on your watchlist

Track score changes the day Lifevantage Corp files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Is LFVN a good stock to buy?

13F Pro's AI-powered analysis of Lifevantage Corp (LFVN) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for LFVN are available on the LFVN stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. LFVN is classified as a small company.

Which hedge funds own LFVN?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling LFVN. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Lifevantage Corp's investment landscape.